Delivery Order SPE2DE21D7001-SPE2D625F75RV
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$1.9K
Federal Agency
Medical Supply Chain
Awardee
Medtronic Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Spring Lake Park, MN 55432, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Health Agency (DHA), an agency within the Department of Defense (DoD), to Medtronic Inc. through its Medtronic USA, Inc. division. The $2,274.30 fixed-price contract with economic price adjustment is for the delivery of BIOLOGICS - DBM-TS-GRAFTON DBF medical products, which are likely specialized surgical implants or biologics used in the treatment of military personnel and veterans. The contract does not have a set-aside designation and is...
The federal contract award SPE2DE21D7001|SPE2D624F5LU2 was issued by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Medtronic Inc. through its Medtronic USA, Inc. division. The $2,875.65 fixed-price delivery order is for the procurement of Grafton Demineralized Bone Matrix (DBM) tissue matrix products, which are advanced surgical implants used in various medical procedures. Medtronic, a global leader in medical technologies, has been awarded this contract...
The U.S. government agency the Defense Health Agency (DHA) awarded a $2,875.65 fixed-price with economic price adjustment delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRIX medical products. This contract does not have a set-aside designation. Medtronic is a global leader in medical technology, specializing in developing and manufacturing innovative medical devices and therapies. As a major supplier...
This federal contract award, with ID SPE2DE21D7001|SPE2D625F7032, was made by the Defense Health Agency (DHA), a component of the Department of Defense, to Medtronic Inc. through its Medtronic USA, Inc. division. The contract, valued at $2,875.65, is for the delivery of BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRIX products. This is a fixed-price delivery order contract with economic price adjustment, with an ultimate completion date of October 18, 2024. Medtronic Inc., a global leader in medical...
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Health Agency (DHA), to Medtronic Inc. through its Medtronic USA, Inc. division. The $11,650.80 fixed-price delivery order is for the supply of BIOLOGICS - DBM-TS-GRAFTON DBF, a biological medical product, with a completion date of May 15, 2024. The contract does not have a set-aside designation. Medtronic is a global leader in medical technology and has been awarded numerous firm fixed-price contracts...
This federal contract award, valued at $5,702.85, was issued by the Defense Health Agency (DHA) to the prime contractor Medtronic Inc. The contract is a fixed-price delivery order with an economic price adjustment, and the ultimate completion date is January 28, 2025. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Medtronic Inc., a global leader in medical technology, will provide biologics - specifically, a Grafton DBM Matrix -...
The U.S. government has awarded a $5,702.85 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of Biologics - DBM-TS-OTI Grafton DBM Matrix medical products. This contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense (DoD) that oversees the Military Health System. The contract has an ultimate completion date of December 9, 2024 and does not have a set-aside designation. Medtronic is a...
This federal contract award, valued at $5,702.85, was issued by the Medical Supply Chain division of the Defense agency to Medtronic Inc., a global medical technology company. The contract is a delivery order to provide BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRI, a type of biological medical device, with a period of performance ending on January 31, 2025. The contract is a fixed-price with economic price adjustment and does not have a set-aside designation, indicating it was competed on a full and...
This federal contract award, with a ceiling value of $3,484.60, was issued by the Medical Supply Chain component of the Defense Health Agency (DHA) to Medtronic Inc., through its Medtronic USA, Inc. division. The contract is a delivery order (SPE2DE21D7001|SPE2D624F1CNQ) for the procurement of BIOLOGICS - DBM-TS-OTI GRAFTON PLUS DBM, a type of medical device. The contract is a fixed price with economic price adjustment type and does not have a set-aside designation. Medtronic Inc., a global...
The U.S. government has awarded a $3,790.50 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of BIOLOGICS - DBM-TS-GRAFTON DBF medical products. This contract was issued by the Defense Health Agency (DHA), a component of the Department of Defense. The contract has no set-aside designation and runs through July 10, 2024. Medtronic is a global leader in medical technology, providing a wide range of innovative medical devices and...